Join us for a psychedelics-focused conversation! Listeners of this podcast episode will enjoy discussions about the basics of serotonin and dopamine, mechanisms of action for psychedelics and antidepressants, different types of patents and their implications, and a dissection of clinical data on the subjective effects of LSD and psilocybin. 

In this episode’s game, Dr. Marcu reads a statement about a drug and panelists guess if it's in reference to a psychedelic compound or an antidepressant. For segment 2 we discuss an article written by Lauren Wilson, published by Lucid News, entitled, “A New Database Seeks to Prevent ‘Bad’ Psychedelic Patents.” This episode's peer reviewed article is a clinical comparison of LSD and psilocybin published in the Nature journal Neuropsychopharmacology in 2022. This episode features Jahan Maruc, PhD, Nigam B. Arora, PhD, Sara Jane Ward, PhD and Amber Wise, PhD.